Aclaris Therapeutics
ACRS • NASDAQ
Aclaris Therapeutics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Neal S. Walker, with a market cap of $494.0M.
Market Cap$494.0M
Employees91.0
CEONeal S. Walker
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
ACR
Aclaris Therapeutics FAQ
Common questions about Aclaris Therapeutics
Aclaris Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $1.3M.
Aclaris Therapeutics has approximately 91 employees.